ClinicalTrials.Veeva

Menu

Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)

U

University Hospital, Gasthuisberg

Status

Completed

Conditions

Lung Cancer
Non Small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01837186
EMPY2013

Details and patient eligibility

About

Empyema following pneumonectomy for Non Small Cell Lung Cancer (NSCLC) is a known problem that occurs in about 2% of pneumonectomy patients.

Full description

The development of an empyema following pneumonectomy is a devastating complication, especially if associated with an underlying fistula. Whilst the perioperative mortality of pneumonectomy overall is now less than 5%, this rises to around 25% when complicated by empyema, and about 50% when associated with fistula. In addition, there is the morbidity and social cost of long-term drainage, chronic sepsis and often multiple operations.

Enrollment

600 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pneumonectomy for NSCLC

Exclusion criteria

  • Pneumonectomy for other reasons (infectious pathology, trauma, mesothelioma, ...)

Trial design

600 participants in 2 patient groups

EFP
Description:
Empyema following pneumonectomy
nEFP
Description:
No empyema following pneumonectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems